Overview

Longitudinal Changes of [18F]PI-2620 Positron Emission Tomography in Subjects With Cognitively Normal, Mild Cognitive Impairment and Alzheimer's Disease

Status:
Recruiting
Trial end date:
2021-02-28
Target enrollment:
Participant gender:
Summary
The overall goal of this imaging trial is to evaluate crosssectional difference and longitudinal changes of [18F]PI-2620, a tau targeted positron emission computed tomography radioligand, in cognitively normal individuals, and subjects with mild cognitive impairment and Alzheimer's disease.
Phase:
Phase 2
Details
Lead Sponsor:
Jae Seung Kim